Combined Ibrutinib and Venetoclax for Patients With Chronic Lymphocytic Leukemia

被引：0
|
作者：
不详
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2020年 / 18卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：16 / 17
页数：2
相关论文
共 50 条
  • [21] Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
    Burger, J. A.
    Tedeschi, A.
    Barr, P. M.
    Robak, T.
    Owen, C.
    Ghia, P.
    Bairey, O.
    Hillmen, P.
    Bartlett, N. L.
    Li, J.
    Simpson, D.
    Grosicki, S.
    Devereux, S.
    McCarthy, H.
    Coutre, S.
    Quach, H.
    Gaidano, G.
    Maslyak, Z.
    Stevens, D. A.
    Janssens, A.
    Offner, F.
    Mayer, J.
    O'Dwyer, M.
    Hellmann, A.
    Schuh, A.
    Siddiqi, T.
    Polliack, A.
    Tam, C. S.
    Suri, D.
    Cheng, M.
    Clow, F.
    Styles, L.
    James, D. F.
    Kipps, T. J.
    Keating, Michael
    Jen, Jie
    Jindra, Pavel
    Simkovic, Martin
    Braester, Andrei
    Ruchlemer, Rosa
    Foa, Roberto
    Semenzato, Gianpietro
    Hawkins, Timothy
    Atanasio, Carolina Moreno
    Demirkan, Fatih
    Kaynar, Leylagul
    Pylypenko, Halyna
    Fox, Christopher
    Thirman, Michael
    Campbell, Philip
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25): : 2425 - 2437
  • [22] Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia
    Roeker, Lindsey E.
    Yazdy, Maryam Sarraf
    Rhodes, Joanna
    Goodfriend, Julie
    Narkhede, Mayur
    Carver, Joseph
    Mato, Anthony
    JAMA NETWORK OPEN, 2019, 2 (12) : E1916326
  • [23] Venetoclax in Patients with Previously Treated Chronic Lymphocytic Leukemia
    Roberts, Andrew W.
    Stilgenbauer, Stephan
    Seymour, John F.
    Huang, David C. S.
    CLINICAL CANCER RESEARCH, 2017, 23 (16) : 4527 - 4533
  • [24] Combination of ibrutinib with immunochemotherapy in patients with chronic lymphocytic leukemia
    Tomowiak, Cecile
    Leleu, Xavier
    HEMATOLOGIE, 2015, 21 (04): : 206 - 207
  • [25] Combined Ibrutinib and Venetoclax for First-Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL): Focus on Long-Term MRD Results
    Jain, Nitin
    Keating, Michael J.
    Thompson, Philip A.
    Ferrajoli, Alessandra
    Burger, Jan A.
    Borthakur, Gautam
    Takahashi, Koichi
    Estrov, Zeev E.
    Sasaki, Koji
    Kadia, Tapan M.
    Konopleva, Marina
    Alvarado, Yesid
    Yilmaz, Musa
    DiNardo, Courtney D.
    Bose, Prithviraj
    Ohanian, Maro
    Pemmaraju, Naveen
    Jabbour, Elias J.
    Kanagal-Shamanna, Rashmi
    Patel, Keyur
    Wang, Wei
    Jorgensen, Jeffrey L.
    Wang, Sa A.
    Garg, Naveen
    Wang, Xuemei
    Wei, Chongjuan
    Cruz, Nichole
    Ayala, Ana
    Plunkett, William
    Kantarjian, Hagop
    Gandhi, Varsha
    Wierda, William G.
    BLOOD, 2021, 138 : 3720 - +
  • [26] Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients
    Mato, A. R.
    Hill, B. T.
    Lamanna, N.
    Barr, P. M.
    Ujjani, C. S.
    Brander, D. M.
    Howlett, C.
    Skarbnik, A. P.
    Cheson, B. D.
    Zent, C. S.
    Pu, J. J.
    Kiselev, P.
    Foon, K.
    Lenhart, J.
    Bachow, S. Henick
    Winter, A. M.
    Cruz, A. -L.
    Claxton, D. F.
    Goy, A.
    Daniel, C.
    Isaac, K.
    Kennard, K. H.
    Timlin, C.
    Fanning, M.
    Gashonia, L.
    Yacur, M.
    Svoboda, J.
    Schuster, S. J.
    Nabhan, C.
    ANNALS OF ONCOLOGY, 2017, 28 (05) : 1050 - 1056
  • [27] Fixed-term strategy combining ibrutinib and venetoclax in the first line of chronic lymphocytic leukemia
    不详
    HEMATOLOGIE, 2022, 28 (04): : 175 - 176
  • [28] Venetoclax for the treatment of chronic lymphocytic leukemia
    Gentile, Massimo
    Petrungaro, Annamaria
    Uccello, Giuseppina
    Vigna, Ernesto
    Recchia, Anna Grazia
    Caruso, Nadia
    Bossio, Sabrina
    De Stefano, Laura
    Palummo, Angela
    Storino, Francesca
    Martino, Massimo
    Morabito, Fortunato
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (11) : 1307 - 1316
  • [29] Venetoclax in the treatment of chronic lymphocytic leukemia
    Korycka-Wolowiec, Anna
    Wolowiec, Dariusz
    Kubiak-Mlonka, Aleksandra
    Robak, Tadeusz
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (05) : 353 - 366
  • [30] Venetoclax and obinutuzumab in chronic lymphocytic leukemia
    Fischer, Kirsten
    Al-Sawaf, Othman
    Fink, Anna-Maria
    Dixon, Mark
    Bahlo, Jasmin
    Warburton, Simon
    Kipps, Thomas J.
    Weinkove, Robert
    Robinson, Sue
    Seiler, Till
    Opat, Stephen
    Owen, Carolyn
    Lopez, Javier
    Humphrey, Kathryn
    Humerickhouse, Rod
    Tausch, Eugen
    Frenzel, Lukas
    Eichhorst, Barbara
    Wendtner, Clemens-M.
    Stilgenbauer, Stephan
    Langerak, Anton W.
    van Dongen, Jacque J. M.
    Boettcher, Sebastian
    Ritgen, Matthias
    Goede, Valentin
    Mobasher, Mehrdad
    Hallek, Michael
    BLOOD, 2017, 129 (19) : 2702 - 2705
12345